Neonatal varicella

Arch Dis Child. 2024 Jul 18;109(8):610-615. doi: 10.1136/archdischild-2022-324820.

Abstract

Primary infection with varicella zoster virus (VZV) in the final 3 weeks of pregnancy may cause transplacental infection and neonatal varicella. Infants are most at risk of severe disease if born from 5 days before to 2 days after onset of the maternal varicella rash. Administration of post-exposure prophylaxis with varicella zoster immunoglobulin and treatment of varicella with aciclovir for those at highest risk of progression to severe disease is advised. Universal vaccination against VZV significantly reduces the incidence of neonatal varicella.

Keywords: Communicable Diseases; Infectious Disease Medicine; Neonatology; Paediatrics; Virology.

Publication types

  • Review

MeSH terms

  • Acyclovir / therapeutic use
  • Antiviral Agents / therapeutic use
  • Chickenpox Vaccine / administration & dosage
  • Chickenpox* / prevention & control
  • Female
  • Herpesvirus 3, Human
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical* / prevention & control
  • Pregnancy
  • Pregnancy Complications, Infectious* / prevention & control

Substances

  • Antiviral Agents
  • Acyclovir
  • Chickenpox Vaccine